Propyphenazone EP impurity C, identified by its CAS number 2731375-50-9, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of analgesic and anti-inflammatory medications. As an impurity, it may arise during the synthesis or degradation of propyphenazone, a non-steroidal anti-inflammatory drug (NSAID). The characteristics of this compound include its molecular structure, which is likely to exhibit functional groups typical of phenazone derivatives, contributing to its pharmacological properties. It may possess moderate solubility in organic solvents and limited solubility in water, which is common for many organic compounds. The compound's stability, reactivity, and potential biological activity would depend on its specific molecular configuration and the presence of substituents. Analytical methods such as chromatography and spectroscopy are often employed to identify and quantify impurities like Propyphenazone EP impurity C in pharmaceutical formulations, ensuring product safety and efficacy. Understanding its characteristics is crucial for quality control in drug manufacturing and compliance with regulatory standards.

Propyphenazone EP impurity C

2731375-50-9: Propyphenazone EP impurity C, identified by its CAS number 2731375-50-9, is a chemical compound that is typically associated with the pharmaceutical industry, particularly in the context of analgesic and anti-inflammatory medications. As an impurity, it may arise during the synthesis or degradation of propyphenazone, a non-steroidal anti-inflammatory drug (NSAID). The characteristics of this compound include its molecular structure, which is likely to exhibit functional groups typical of phenazone derivatives, contributing to its pharmacological properties. It may possess moderate solubility in organic solvents and limited solubility in water, which is common for many organic compounds. The compound's stability, reactivity, and potential biological activity would depend on its specific molecular configuration and the presence of substituents. Analytical methods such as chromatography and spectroscopy are often employed to identify and quantify impurities like Propyphenazone EP impurity C in pharmaceutical formulations, ensuring product safety and efficacy. Understanding its characteristics is crucial for quality control in drug manufacturing and compliance with regulatory standards.

CAS 2731375-50-9

Propyphenazone EP impurity C

4-[(1RS)-1,3-Dimethylbutyl]-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one

Ref: 86-MM0036.04